Bu_2022_J.Alzheimers.Dis__

Reference

Title : Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System - Bu_2022_J.Alzheimers.Dis__
Author(s) : Bu K , Patel D , Morris R , Han W , Umeukeje G , Zhu T , Cheng F
Ref : J Alzheimers Dis , : , 2022
Abstract : Bu_2022_J.Alzheimers.Dis__
ESTHER : Bu_2022_J.Alzheimers.Dis__
PubMedSearch : Bu_2022_J.Alzheimers.Dis__
PubMedID: 35964196

Related information

Citations formats

Bu K, Patel D, Morris R, Han W, Umeukeje G, Zhu T, Cheng F (2022)
Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System
J Alzheimers Dis :

Bu K, Patel D, Morris R, Han W, Umeukeje G, Zhu T, Cheng F (2022)
J Alzheimers Dis :